HHS takes action against Gilead; a report on fears of seasonal workers in Montana; the latest CDC data on preventable deaths show differences between urban and rural areas.
After failing to reach a licensing deal with Gilead, HHS sued the drug maker in federal court, saying the company is infringing on patents held by CDC and paid for by taxpayers. AIDS activists maintain that the government could use the royalties to fund HIV prevention and treatment services. Gilead said in a statement the patents are not valid, STAT News reported.
Seasonal workers in Montana who had been eligible for health coverage under Medicaid expansion worry they may lose access to benefits due to new reporting requirements that could go into effect in January, according to Kaiser Health News. However, similar work requirement laws were blocked this year in Arkansas, Kentucky, and New Hampshire.
In 2017, the 5 leading causes of death for persons older than 80 years in the United States were heart disease, cancer, unintentional injury, chronic lower respiratory disease, and stroke, according to data released Thursday in the CDC's Morbidity and Mortality Weekly Report. For the study period, percentages were higher for all 5 in nonmetropolitan counties.
What It Takes to Improve Guideline-Based Heart Failure Care With Ty J. Gluckman, MD
August 5th 2025Explore innovative strategies to enhance heart failure treatment through guideline-directed medical therapy, remote monitoring, and artificial intelligence–driven solutions for better patient outcomes.
Listen
Elevating Equitable Health Care for the LGBTQ+ Community
June 18th 2024For the third episode in our special Pride Month series, we speak with Patrick McGovern, CEO of Callen-Lorde since August of 2023 and an outspoken advocate for HIV; lesbian, gay, bisexual, transgender, queer, plus (LGBTQ+); and community health.
Listen
Assessment of Variation in Ambulatory Cardiac Monitoring Among Commercially Insured Patients
August 13th 2025Ambulatory cardiac monitors’ clinical and economic outcomes vary; one long-term continuous monitor brand showed greater arrhythmia diagnosis, fewer retests and cardiovascular events, and lower health care resource use and costs.
Read More
Semaglutide Linked to Cardiovascular Gains, but Also Higher Health Spending
August 8th 2025A real-world study found that semaglutide prescriptions were associated with improvements in weight, blood pressure, and cholesterol, but also a $80 monthly rise in health care spending outside of drug costs.
Read More